Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | survival of motor neuron 2, centromeric | Starlite/ChEMBL | No references |
Homo sapiens | K(lysine) acetyltransferase 2A | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Homo sapiens | arachidonate 15-lipoxygenase, type B | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0116 | 0.0116 |
Echinococcus multilocularis | arachidonate 5 lipoxygenase | 0.0142 | 0.0618 | 0.0537 |
Schistosoma mansoni | survival motor neuron protein | 0.0058 | 0.0104 | 0.0104 |
Trypanosoma brucei | hexokinase | 0.168 | 1 | 0.5 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0175 | 0.0817 | 0.0817 |
Onchocerca volvulus | 0.168 | 1 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0.3008 | 0.3008 |
Echinococcus multilocularis | hexokinase | 0.168 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.1054 | 0.618 | 0.618 |
Loa Loa (eye worm) | hexokinase type II | 0.168 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0286 | 0.1491 | 0.1491 |
Toxoplasma gondii | hexokinase | 0.168 | 1 | 1 |
Leishmania major | hexokinase, putative | 0.168 | 1 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.052 | 0.2921 | 0.2921 |
Schistosoma mansoni | hypothetical protein | 0.0058 | 0.0104 | 0.0104 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0051 | 0.0063 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0116 | 0.0116 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0086 | 0.0023 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0086 | 0.0086 |
Entamoeba histolytica | hexokinase 1 | 0.168 | 1 | 1 |
Echinococcus granulosus | hexokinase type 2 | 0.168 | 1 | 1 |
Trypanosoma cruzi | hexokinase, putative | 0.168 | 1 | 0.5 |
Echinococcus granulosus | survival motor neuron protein 1 | 0.0286 | 0.1491 | 0.1438 |
Onchocerca volvulus | 0.168 | 1 | 1 | |
Echinococcus multilocularis | hexokinase | 0.168 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.168 | 1 | 1 |
Echinococcus granulosus | hexokinase | 0.168 | 1 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0116 | 0.0116 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.0629 | 0.0629 |
Echinococcus granulosus | hexokinase | 0.168 | 1 | 1 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.0629 | 0.0629 |
Echinococcus granulosus | arachidonate 5 lipoxygenase | 0.0142 | 0.0618 | 0.0559 |
Leishmania major | hexokinase, putative | 0.168 | 1 | 0.5 |
Schistosoma mansoni | lipoxygenase | 0.01 | 0.0356 | 0.0356 |
Trypanosoma brucei | hexokinase | 0.168 | 1 | 0.5 |
Brugia malayi | Hexokinase family protein | 0.168 | 1 | 1 |
Treponema pallidum | hexokinase (hxk) | 0.168 | 1 | 0.5 |
Plasmodium falciparum | hexokinase | 0.168 | 1 | 1 |
Loa Loa (eye worm) | hexokinase | 0.168 | 1 | 1 |
Echinococcus multilocularis | hexokinase | 0.168 | 1 | 1 |
Onchocerca volvulus | Hexokinase homolog | 0.1054 | 0.618 | 0.614 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0175 | 0.0817 | 0.0737 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0055 | 0.0086 | 0.0086 |
Echinococcus multilocularis | hexokinase type 2 | 0.168 | 1 | 1 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0055 | 0.0086 | 0.0086 |
Brugia malayi | Hexokinase family protein | 0.1054 | 0.618 | 0.618 |
Brugia malayi | Hexokinase family protein | 0.052 | 0.2921 | 0.2921 |
Plasmodium vivax | hexokinase, putative | 0.168 | 1 | 1 |
Onchocerca volvulus | 0.168 | 1 | 1 | |
Schistosoma mansoni | hexokinase | 0.168 | 1 | 1 |
Schistosoma mansoni | lipoxygenase | 0.0142 | 0.0618 | 0.0618 |
Loa Loa (eye worm) | hypothetical protein | 0.0534 | 0.3008 | 0.3008 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0116 | 0.0116 |
Brugia malayi | hypothetical protein | 0.0286 | 0.1491 | 0.1491 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.017 | 0.0787 | 0.0729 |
Brugia malayi | hexokinase type II | 0.0534 | 0.3008 | 0.3008 |
Trypanosoma brucei | hexokinase, putative | 0.168 | 1 | 0.5 |
Loa Loa (eye worm) | acetyltransferase | 0.0175 | 0.0817 | 0.0817 |
Echinococcus granulosus | hexokinase | 0.168 | 1 | 1 |
Onchocerca volvulus | 0.1054 | 0.618 | 0.614 | |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0051 | 0.0063 | 0.5 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0175 | 0.0817 | 0.0817 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0055 | 0.0086 | 0.0023 |
Echinococcus multilocularis | survival motor neuron protein 1 | 0.0286 | 0.1491 | 0.1418 |
Trypanosoma cruzi | hexokinase, putative | 0.168 | 1 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0086 | 0.0086 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0055 | 0.0086 | 0.0086 |
Brugia malayi | Iron-sulfur cluster assembly accessory protein | 0.0058 | 0.0104 | 0.0104 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0047 | 0.0037 | 0.5 |
Entamoeba histolytica | hexokinase 2 | 0.168 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.1146 | 0.6741 | 0.6741 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.0629 | 0.0629 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.2617 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 0.5623 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 0.8913 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of GCN5L2. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504398] | ChEMBL. | No reference |
Potency (functional) | 2.2387 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 15.8489 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID2312, AID2537, AID2702] | ChEMBL. | No reference |
Potency (functional) | = 17.7828 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 19.9526 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 25.1189 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.